Salivary gland dysfunction has been described in patients undergoing radioiodine therapy
but associated lacrimal gland dysfunction (sicca syndrome) has never been reported. We …

Objective. To evaluate systemic involvement in primary SS in a large cohort of Spanish
patients using the EULAR-SS disease activity index (ESSDAI) definitions. Methods. Systemic …

Introduction: Off-label rituximab is commonly used for patients with systemic lupus
erythematosus (SLE) with extrarenal disease activity. Methods: The outcomes and tolerability of …

OBJECTIVE: To assess the risk and predictors of lymphoma development in a large cohort
of patients with primary Sjögren's syndrome (pSS). METHODS: Cox-regression analyses …

OBJECTIVE: To review all cases of concurrent vasculitis and solid tumors diagnosed at our
Department over a 15-year period and explore evidence that would support the notion of …

Cerebrovascular accidents (CVAs) and multi-infarct dementia have rarely been reported as
presenting symptoms of giant cell arteritis (GCA), although 3%-4% of patients with GCA may …

Early access to medicines allows the prescription of a medicine before it is available in the
public formulary to patients with severe or rare diseases with high unmet needs who have no …

… Amparo GarcIa-Burillo, Joan Castell, Manel Fraile, Carlos Jacas, Miquel Vilardell,
Domingo Ortega and Josep-Angel Bosch … Bosch JA, MontalbánJ, Vilardell M …

Off-label use of rituximab is commonly requested for patients with resistant nephropathies.
The outcomes and tolerability of rituximab in adult patients with nephropathy treated at our …

Sjögren’s syndrome (SS) is an autoimmune disease characterized by production of
antibodies and lymphocytic infiltration of the salivary and lacrimal glands, leading to their …